Compounds > cimoxatone
Page last updated: 2024-08-23

cimoxatone and 3,4-dihydroxyphenylacetic acid

cimoxatone has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waldmeier, PC1

Other Studies

1 other study(ies) available for cimoxatone and 3,4-dihydroxyphenylacetic acid

ArticleYear
On the reversibility of reversible MAO inhibitors.
    Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 329, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Brain; Clorgyline; Dopamine; Female; Homovanillic Acid; Kinetics; Liver; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Phenethylamines; Piperidines; Rats; Rats, Inbred Strains; Serotonin

1985